Cumberland Pharmaceuticals Acquired by Apotex | Healthcare M&A Deal

Apotex has agreed to acquire Cumberland Pharmaceuticals, a pharmacy business in Tennessee, for $100 million. Cumberland Pharmaceuticals commercializes FDA-approved specialty medicines including Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ, supporting branded pharmacy distribution in Nashville, TN. Apotex acquisitions in healthcare M&A aim to expand its U.S. branded specialty platform through a divestiture acquisition of Cumberland assets tied to these products. The strategic acquisition is structured as an asset purchase agreement, with cash consideration paid at closing and Cumberland retaining ifetroban product candidates and Cumberland Emerging Technologies.